MID Atlantic Renal Coalition Inc

“Coinciding with the second option year renewal of the End Stage Renal Disease (ESRD) Network contract, the Centers for Medicare & Medicaid Services (CMS) significantly expanded the organizational structure section of the contract. To comply with these changes, the MARC bylaws were amended to address new diversity, attendance, committee, training and public posting requirements.”

“Quality Insights Holdings, Inc. is the sole member of Mid-Atlantic Renal Coalition, Inc.”

“Quality Insights Holdings, Inc. shall appoint all members of the Organization's board of directors.”

“Quality Insights Holdings, Inc. shall have sole authority and power with respect to amending the certificate of incorporation, amending the bylaws, adopting an agreement of merger or consolidation, approving the sale, lease or exchange of all or substantially all of the Organization's property and assets, or approving the dissolution of the Organization or a revocation of a dissolution.”

“The completed Form 990 is provided electronically for review by the Organization's board. Additionally, the Controller and the Chief Financial Officer perform a detailed review and verify all financial information against the Organization's audited financial statements and supporting accounting records.”

“The Organization regularly and consistently monitors and enforces compliance with its conflict disclosure policies. All board members, officers and employees complete and sign a conflict disclosure form that lists affiliations and compensation arrangements for themselves and family members that could create a potential conflict of interest. This is accomplished as part of annual compliance training. The training itself addresses conflicts of interest. Conflict of interest certifications are reviewed by the Corporate Compliance Officer and/or the Medicare Compliance Officer to identify any relationships or interests that may pose potential conflicts. Established procedures require a board member to recuse herself/himself from evaluation of a proposed business arrangement if the board member has a potential conflict. In the case of employees, the Corporate Compliance Officer works with the employee's supervisor to determine whether a potential conflict may be mitigated.”

“Compensation arrangements are established based on information obtained from different data sources and outside consultants for similarly situated taxable or tax exempt organizations providing similar services. The compensation plan is reviewed and approved by Quality Insights Holdings, Inc.'s board on an annual basis. This process is the same for both the CEO and all officers.”

“The Organization may make its governing documents, conflict of interest policy, or financial statements available to the public, upon request, on a case-by-case basis.”

“Quality Insights Holdings, Inc. (QIH), and its subsidiaries, consisting of West Virginia Medical Institute, Inc. (WVMI), Quality Insights of Delaware, Inc. (QID), Quality Insights of Pennsylvania, Inc. (QIP), Quality Insights Renal Network, Inc. (QIRN) and Mid-Atlantic Renal Coalition, Inc. (MARC), merged after the close of business on December 31, 2015. Commencing with the start of business on January 1, 2016, the merged entities will operate as WVMI, under WVMI's previously existing corporate charter. WVMI will continue to seek to further the shared missions of the previously existing entities of advancing the practice of medicine and improving the quality, utilization and delivery of medical care through the administration of educational and quality improvement programs and to obtain administrative efficiencies. QIH, along with QID, QIP, QIRN and MARC, ceased to exist after the close of business on December 31, 2015. Effective with the merger, the Board of Directors of WVMI will consist of the QIH Board of Directors that was in place prior to the close of business on December 31, 2015.”

“Other Fees: Program service expenses 382,795. Management and general expenses 0. Fundraising expenses 0. Total expenses 382,795.”

“Transfer of assets for merger effective at close of business on 12/31/15 -2,896,502.”